Evaluation of expression pattern of cellular miRNAs (let-7b, miR-29a, miR-126, miR-34a, miR-181a-5p) and IL-6, TNF-α, and TGF-β in patients with pseudoexfoliation syndrome.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 25 05 2023
revised: 20 07 2023
accepted: 26 07 2023
medline: 12 9 2023
pubmed: 18 8 2023
entrez: 17 8 2023
Statut: ppublish

Résumé

Pseudoexfoliation syndrome (PEX) is a critical clinical and biological extracellular matrix systemic disorder. Despite the unknown nature of PEX etiopathogenesis, it is proven to be associated with various genes and factors. The present research focused on analyzing the expression of miR and inflammatory cytokines in PEX. Serum and aqueous humor (AH) were collected prior to cataract surgery or trabeculectomy from 99 participants (64 with PEX glaucoma, and 35 controls). Real-time PCR was used for assessing the expression pattern of some miRNAs namely let-7b, miR-29a, miR-126, miR-34a, and miR-181a-5p. ELISA was carried out to explore the transcription of some inflammatory cytokines such as TGF-β, TNF-α, and IL-6. The indication of our results was a significant enhancement in the expression of let-7, miR-34a, and miR-181a-5p in PEX in contrast to the control group. Notwithstanding a significant suppression in miR-29a, and miR-126 expression levels in PEX in contrast to the control group. Analysis of ROC curve revealed that miR-29a and miR-34a are able to act as useful markers in order to discriminate the PEX group from the PEX negative subjects which were determined as the control group. According to the results obtained, the mean levels of TGF-β, TNF-α, and IL-6 upregulated among PEX subjects in contrast to control samples. In conclusion, our findings indicated that the selected cytokines alongside the selected miRNAs could be introduced as a biomarker panel in the diagnosis of PEX.

Identifiants

pubmed: 37591069
pii: S0344-0338(23)00421-1
doi: 10.1016/j.prp.2023.154721
pii:
doi:

Substances chimiques

MicroRNAs 0
Tumor Necrosis Factor-alpha 0
Interleukin-6 0
Transforming Growth Factor beta 0
Cytokines 0
MIRN126 microRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154721

Informations de copyright

Copyright © 2023 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict of interest.

Auteurs

Bahar Banasaz (B)

Internal Medicine Department, Babol University of Medical Sciences, Babol, Islamic Republic of Iran.

Razieh Zamzam (R)

School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Davood Aghadoost (D)

Department of Ophthalmology, General Ophthalmologist, Matini Hospital, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Khodayar Golabchi (K)

Department of Ophthalmology, General Ophthalmologist, Matini Hospital, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Mohammadamin Morshedi (M)

School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Mobina Bayat (M)

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.

Javid Sadri Nahand (J)

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.

Amirhossein Sheida (A)

School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Reza Eshraghi (R)

School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Zoha Rahimzadeh (Z)

School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Seyed Gholamabbas Mosavi (SG)

Biostatistics Group, Health Faculty, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Pouya Goleij (P)

Department of Genetics, Faculty of Biology, Sana Institute of Higher Education, Sari, Islamic Republic of Iran.

Aryan Rezaee (A)

Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran. Electronic address: Rezaee.aryan@gmail.com.

Hamed Mirzaei (H)

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University, Kashan, Islamic Republic of Iran. Electronic address: mirzaei-h@kaums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH